Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4618

1.

Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease.

Cho HJ, Yang SI, Kim KH, Kim JN, Kil HR.

Korean J Pediatr. 2014 May;57(5):217-21. doi: 10.3345/kjp.2014.57.5.217. Epub 2014 May 31.

PMID:
25045363
[PubMed]
Free PMC Article
2.

Giant coronary artery aneurysms in a 58-year-old.

Singhi AK, Pavithran S, Sivakumar K.

Ann Pediatr Cardiol. 2014 May;7(2):152-4. doi: 10.4103/0974-2069.132502.

PMID:
24987266
[PubMed]
Free PMC Article
3.

The Harada Score in the US Population of Children With Kawasaki Disease.

Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.

Hosp Pediatr. 2014 Jul;4(4):233-8. doi: 10.1542/hpeds.2014-0008.

PMID:
24986993
[PubMed - in process]
4.

Risk factors for retropharyngeal cellulitis in Kawasaki disease.

Tona R, Shinohara S, Fujiwara K, Kikuchi M, Kanazawa Y, Kishimoto I, Harada H, Naito Y.

Auris Nasus Larynx. 2014 Jun 20. pii: S0385-8146(14)00100-X. doi: 10.1016/j.anl.2014.05.017. [Epub ahead of print]

PMID:
24958366
[PubMed - as supplied by publisher]
5.

Rupture of a coronary artery aneurysm in Kawasaki disease: a rare case and review of the literature for the past 15 years.

Miyamoto T, Ikeda K, Ishii Y, Kobayashi T.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):e67-9. doi: 10.1016/j.jtcvs.2014.02.035. Epub 2014 Feb 14. Review. No abstract available.

PMID:
24837735
[PubMed - indexed for MEDLINE]
6.

Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

Lin MC.

World J Pediatr. 2014 May;10(2):114-8. doi: 10.1007/s12519-014-0479-8. Epub 2014 May 7.

PMID:
24801230
[PubMed - in process]
7.

[Pathophysiology of medium-and small vessel vasculitis].

Yamada H.

Nihon Jinzo Gakkai Shi. 2014;56(2):98-104. Review. Japanese. No abstract available.

PMID:
24730347
[PubMed - indexed for MEDLINE]
8.

Monitoring of the serum proteome in Kawasaki disease patients before and after immunoglobulin therapy.

Zhang L, Jia HL, Huang WM, Liu CW, Hua L, Liu TC, Mao LJ, Xu YF, Li W, Xia SL, Gan YY, Deng L, Zhang G.

Biochem Biophys Res Commun. 2014 Apr 25;447(1):19-25. doi: 10.1016/j.bbrc.2014.03.108. Epub 2014 Mar 29.

PMID:
24690176
[PubMed - indexed for MEDLINE]
9.

The epidemiology and clinical features of Kawasaki disease in Australia.

Saundankar J, Yim D, Itotoh B, Payne R, Maslin K, Jape G, Ramsay J, Kothari D, Cheng A, Burgner D.

Pediatrics. 2014 Apr;133(4):e1009-14. doi: 10.1542/peds.2013-2936. Epub 2014 Mar 31.

PMID:
24685950
[PubMed - indexed for MEDLINE]
10.

[Systemic vasculitis].

Fain O, Mekinian A.

Rev Prat. 2014 Jan;64(1):113-26. Review. French. No abstract available.

PMID:
24649563
[PubMed - indexed for MEDLINE]
11.

History of Kawasaki disease.

Kawasaki T, Naoe S.

Clin Exp Nephrol. 2014 Apr;18(2):301-4. doi: 10.1007/s10157-013-0877-6. Epub 2014 Mar 6.

PMID:
24595558
[PubMed - in process]
12.

Treatment of Kawasaki disease with anti-TNF antibodies.

Levin M, Burgner D.

Lancet. 2014 May 17;383(9930):1700-3. doi: 10.1016/S0140-6736(14)60131-8. Epub 2014 Feb 24. No abstract available.

PMID:
24572998
[PubMed - indexed for MEDLINE]
13.

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.

Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24.

PMID:
24572997
[PubMed - indexed for MEDLINE]
14.

Infliximab plus plasma exchange rescue therapy in Kawasaki disease.

Sonoda K, Mori M, Hokosaki T, Yokota S.

J Pediatr. 2014 May;164(5):1128-1132.e1. doi: 10.1016/j.jpeds.2014.01.020. Epub 2014 Feb 20.

PMID:
24560183
[PubMed - indexed for MEDLINE]
15.

[Kawasaki disease in children: epidemiology, clinical symptoms, diagnostics and treatment].

Iwańczak B, Krynicka-Scaringella O.

Pol Merkur Lekarski. 2013 Dec;35(210):375-8. Review. Polish.

PMID:
24490469
[PubMed - indexed for MEDLINE]
16.

Diagnosis and classification of Kawasaki disease.

Sánchez-Manubens J, Bou R, Anton J.

J Autoimmun. 2014 Feb-Mar;48-49:113-7. doi: 10.1016/j.jaut.2014.01.010. Epub 2014 Jan 28.

PMID:
24485156
[PubMed - in process]
17.

Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease.

Thors VS, Vastert SJ, Wulffraat N, van Royen A, Frenkel J, de Sain-van der Velden M, de Koning TJ.

Pediatrics. 2014 Feb;133(2):e461-5. doi: 10.1542/peds.2012-1372. Epub 2014 Jan 27.

PMID:
24470648
[PubMed - indexed for MEDLINE]
18.

[Expression of myeloid-related protein complex in association with circulating endothelial cells in children with acute Kawasaki disease].

Wang CJ, Chen M, Lei ZJ.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jan;16(1):48-52. Chinese.

PMID:
24461178
[PubMed - indexed for MEDLINE]
Free Article
19.

[Changes in serum levels of resistin and visfatin in pediatric patients with acute Kawasaki disease following intravenous immune globulin treatment].

Fu SF, Yu DL, Lv DY, Chen FY.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jan;16(1):44-7. Chinese.

PMID:
24461177
[PubMed - indexed for MEDLINE]
Free Article
20.

Long-term cardiovascular outcomes in survivors of Kawasaki disease.

Holve TJ, Patel A, Chau Q, Marks AR, Meadows A, Zaroff JG.

Pediatrics. 2014 Feb;133(2):e305-11. doi: 10.1542/peds.2013-1638. Epub 2014 Jan 20.

PMID:
24446449
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk